Department of Experimental Pharmacology, University of Naples Federico II, 80131 Naples, Italy.
Mediators Inflamm. 2013;2013:584715. doi: 10.1155/2013/584715. Epub 2013 Jan 21.
Macrophages play crucial roles in atherosclerotic immune responses. Recent investigation into macrophage autophagy (AP) in atherosclerosis has demonstrated a novel pathway through which these cells contribute to vascular inflammation. AP is a cellular catabolic process involving the delivery of cytoplasmic contents to the lysosomal machinery for ultimate degradation and recycling. Basal levels of macrophage AP play an essential role in atheroprotection during early atherosclerosis. However, AP becomes dysfunctional in the more advanced stages of the pathology and its deficiency promotes vascular inflammation, oxidative stress, and plaque necrosis. In this paper, we will discuss the role of macrophages and AP in atherosclerosis and the emerging evidence demonstrating the contribution of macrophage AP to vascular pathology. Finally, we will discuss how AP could be targeted for therapeutic utility.
巨噬细胞在动脉粥样硬化的免疫反应中起着至关重要的作用。最近对动脉粥样硬化中巨噬细胞自噬 (AP) 的研究表明,这些细胞通过一种新的途径促进血管炎症。AP 是一种细胞分解代谢过程,涉及将细胞质内容物递送至溶酶体机制进行最终降解和再循环。巨噬细胞 AP 的基础水平在早期动脉粥样硬化的动脉保护中起着至关重要的作用。然而,AP 在病理学的更晚期阶段变得功能失调,其缺乏会促进血管炎症、氧化应激和斑块坏死。在本文中,我们将讨论巨噬细胞和 AP 在动脉粥样硬化中的作用,以及证明巨噬细胞 AP 对血管病理学的贡献的新证据。最后,我们将讨论如何针对 AP 进行治疗。